Journal of Dermatological Treatment

Editorial
pp. 7-7(1)
Author: Richard Groves

Single-center retrospective study of long-term use of low-dose acitretin (Soriatane^®) for psoriasis
pp. 8-13(6)
Authors: E Lee; J Koo

Double-blind, randomised, multicentre, parallel group study comparing a 1% coal tar preparation (Exorex) with a 5% coal tar preparation (Alphosyl) in chronic plaque psoriasis
pp. 14-22(9)
Authors: M Goodfield; S Kownacki; J Berth-Jones

Fumaric acid esters in the treatment of psoriasis: an Italian experience
pp. 23-26(4)
Authors: I Carboni; C De Felice; I De Simoni; R Soda; S Chimenti

A quantitative definition of severe psoriasis for use in clinical trials
pp. 27-29(3)
Author: SR Feldman

A multicenter trial of the efficacy and safety of 0.03% tacrolimus ointment for atopic dermatitis in Korea
pp. 30-34(5)
Authors: CH Won; PG Seo; YM Park; JM Yang; KH Lee; KJ Sung; CW Park; DW Kim; HS Chang; YH Won; KH Kim

Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study
pp. 35-39(5)
Authors: CB Hollar; JL Jorizzo

Pityriasis versicolor: quality of studies
pp. 40-45(6)
Authors: AK Gupta; K Nicol; A Johnson

Intravenous immunoglobulin (IVIg) for therapy-resistant cutaneous lupus erythematosus (LE)
pp. 46-50(5)
Authors: M Goodfield; K Davison; K Bowden

Inhibition of cold urticaria by desloratadine
pp. 51-59(9)
Author: L Juhlin

Comparative efficacy of cetirizine and fexofenadine in the treatment of chronic idiopathic urticaria
pp. 55-57(3)
Authors: S Handa; S Dogra; B Kumar

An unusual late onset closed-comedone naevus: successful therapy with light cautery and a topical retinoid
pp. 58-59(2)
Authors: KF Baxter; AS Highet; WJ Cunliffe

Pemphigus foliaceus: an adverse reaction to lisinopril
pp. 60-62(3)
Authors: CRS Patterson; MG Davies

0.1% Tacrolimus ointment in a patient with subacute cutaneous lupus erythematosus
pp. 63-64(2)
Authors: A Drüke; T Gambichler; P Altmeyer; M. Freitag; A. Kreuter